New oral anticoagulants: should they replace heparins and warfarin?

Hellenic J Cardiol. 2011 Jan-Feb;52(1):52-67.
No abstract available

Publication types

  • Review

MeSH terms

  • Anticoagulants / pharmacology*
  • Benzamides / pharmacology
  • Benzamides / therapeutic use
  • Benzimidazoles / administration & dosage
  • Benzimidazoles / pharmacology
  • Benzimidazoles / therapeutic use
  • Dabigatran
  • Factor Xa Inhibitors
  • Heparin / therapeutic use
  • Heparin Antagonists / pharmacology
  • Heparin, Low-Molecular-Weight / pharmacology
  • Humans
  • Morpholines / pharmacology
  • Morpholines / therapeutic use
  • Protamines / pharmacology
  • Pulmonary Embolism / drug therapy
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use
  • Pyridines / administration & dosage
  • Pyridines / pharmacology
  • Pyridines / therapeutic use
  • Pyridones / pharmacology
  • Pyridones / therapeutic use
  • Rivaroxaban
  • Thiophenes / pharmacology
  • Thiophenes / therapeutic use
  • Venous Thromboembolism / prevention & control*
  • Venous Thrombosis / drug therapy
  • Vitamin K / antagonists & inhibitors*
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Benzamides
  • Benzimidazoles
  • Factor Xa Inhibitors
  • Heparin Antagonists
  • Heparin, Low-Molecular-Weight
  • Morpholines
  • Protamines
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Thiophenes
  • Vitamin K
  • apixaban
  • Warfarin
  • betrixaban
  • Heparin
  • Rivaroxaban
  • Dabigatran